Pharma as a strategic industry: how warehousing in Cheb supports Germany’s pharmaceutical sector

Strengthening pharma means strengthening the entire value chain

The September 2026 paper “Fokussierung, Souveränität und neue Wertschöpfung. Eine industrie- und wirtschaftspolitische Strategie für Deutschland” identifies pharmaceuticals, biotechnology and medical technology as priority sectors. It links a more focused industrial policy with European cooperation and resilience.

Our conclusion is that strengthening Germany’s pharmaceutical sector requires attention to qualified warehousing and distribution alongside research and manufacturing. A manufactured medicine contributes to supply only when it is available at the right place and time with its quality preserved. The assessment of warehousing in Cheb is Inter-Pharma’s interpretation; the paper’s authors do not recommend this location.

Cheb: European warehousing infrastructure serving Germany

Cheb is in western Czechia, close to the German border. It combines proximity to Germany with access to Czechia and other European markets. Inter-Pharma operates its own warehousing and fulfilment processes there. Infrastructure outside Germany can therefore directly support the delivery capability of German pharmaceutical companies.

Its value depends on controlled processes: available inventory, clear stock status, traceable batches and expiry dates, and coordinated handovers. Border proximity alone does not meet these requirements. Pharmaceutical warehousing and GDP storage in Cheb →

The operational contribution of warehousing in Cheb

An agreed warehousing model in Cheb can serve several purposes for manufacturers and pharmaceutical businesses:

• Manufacturing and distribution buffers: separate inbound deliveries from customer call-offs while retaining inventory control.
• Launches and growth: coordinate initial stock, orders and dispatch preparation.
• Risk-based reserves: align product-specific safety stocks with consumption, expiry and working capital.
• European product flows: connect stock management, order picking, packing checks and dispatch preparation to the agreed destination countries and recipients.

Inter-Pharma’s own operations in Cheb and additional transport by qualified partners are defined separately in the project scope. Additional storage can cushion disruption; it does not automatically resolve manufacturing problems or other causes of shortages.

GDP quality determines the value of storage

The EU Guidelines on Good Distribution Practice for medicinal products for human use provide the professional framework. Temperature, stock status, traceability, deviations and recall processes must work together. Warehousing is a quality-critical service, not simply a pallet position.

Inter-Pharma plans storage in Cheb around product requirements. The website describes processes for 15–25 °C; requirements for 2–8 °C, specific product groups and available capacity are assessed and confirmed for each project. Quality agreements, responsibilities and contingency processes must be settled before operations begin.

Supply resilience has an economic value

For Germany’s strategic pharmaceutical industry, a European warehousing structure contributes by preserving quality, supporting delivery capability and making distribution predictable. Research and manufacturing investment need a dependable connection to the market. Cheb can support that connection as an additional storage location.

Reserve capacity, safety stocks and qualified processes carry costs. Resilience requirements should be reflected in service agreements and remuneration. Useful measures include inventory accuracy, agreed order processing, temperature deviations and documented response times. The assessment should focus on the actual contribution to German supply and value creation, including within a cross-border European structure.

From industrial strategy to a defined warehousing project

A viable project starts with products, temperature profiles, volumes and orders, batch and expiry data, stock status, destination markets and interfaces. These determine confirmed capacity, the quality agreement, handovers and a controlled go-live.

Inter-Pharma translates an industrial-policy goal into an operational task: organising pharmaceutical warehousing in Cheb to support German pharmaceutical companies and their European supply chains. Discuss a warehousing project in Cheb →

Download the original paper (German PDF, 29 pages)

Unchanged German-language original, September 2026. The descriptive filename reflects this news article’s focus; the PDF itself has not been edited.

Download the original paper (German PDF, 29 pages)

Authors of the strategy paper: Christian Agethen, Carolin Albrecht, Frederik Digulla, Sebastian Dullien, Thomas Losse-Müller, Jens Südekum, Jakob von Weizsäcker.